We are live on ! Find out more
TNB

Thomasville National Bank Portfolio holdings

AUM $1.82B
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$547M
AUM Growth
+$44.2M
Cap. Flow
+$35.8M
Cap. Flow %
6.54%
Top 10 Hldgs %
28.45%
Holding
263
New
29
Increased
142
Reduced
52
Closed
13

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.9M
2
NVO
Novo Nordisk
NVO
+$2.63M
3
COR icon
Cencora
COR
+$2.62M
4
DGX icon
Quest Diagnostics
DGX
+$1.41M
5
RRC icon
Range Resources
RRC
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 16.09%
2 Healthcare 12.13%
3 Consumer Staples 10.51%
4 Industrials 9.83%
5 Technology 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COF icon
26
Capital One
COF
$136B
$6.96M 1.27%
84,190
+2,679
+3% +$218K
BIIB icon
27
Biogen
BIIB
$30.8B
$6.51M 1.19%
23,998
+1,360
+6% +$360K
XOM icon
28
ExxonMobil
XOM
$641B
$6.41M 1.17%
79,377
+4,244
+6% +$347K
EXPE icon
29
Expedia Group
EXPE
$37.1B
$5.3M 0.97%
35,603
+2,488
+8% +$349K
SO icon
30
Southern Company
SO
$107B
$5.13M 0.94%
107,109
+2,028
+2% +$102K
CELG
31
DELISTED
Celgene Corp
CELG
$4.87M 0.89%
+37,525
New +$4.6M
VZ icon
32
Verizon
VZ
$195B
$4.63M 0.85%
103,589
+2,899
+3% +$135K
FDX icon
33
FedEx
FDX
$74.1B
$4.58M 0.84%
21,056
+1,134
+6% +$224K
T icon
34
AT&T
T
$160B
$4.36M 0.8%
153,122
+2,917
+2% +$86K
AMGN icon
35
Amgen
AMGN
$210B
$4.35M 0.8%
25,269
+2,563
+11% +$417K
IJR icon
36
iShares Core S&P Small-Cap ETF
IJR
$113B
$4.22M 0.77%
60,225
+43,640
+263% +$3.02M
JNJ icon
37
Johnson & Johnson
JNJ
$612B
$4.16M 0.76%
31,472
+3,873
+14% +$494K
MCD icon
38
McDonald's
MCD
$189B
$4.06M 0.74%
26,502
+1,540
+6% +$223K
ABBV icon
39
AbbVie
ABBV
$432B
$3.8M 0.69%
52,387
+1,506
+3% +$101K
MRK icon
40
Merck
MRK
$318B
$3.76M 0.69%
61,535
+4,438
+8% +$270K
WMT icon
41
Walmart Inc
WMT
$884B
$3.7M 0.68%
146,565
+12,018
+9% +$305K
PEP icon
42
PepsiCo
PEP
$190B
$3.67M 0.67%
31,735
+252
+0.8% +$28.9K
SHPG
43
DELISTED
Shire pic
SHPG
$3.5M 0.64%
21,204
+1,188
+6% +$208K
AFL icon
44
Aflac
AFL
$63.9B
$3.39M 0.62%
87,334
+666
+0.8% +$25K
PM icon
45
Philip Morris
PM
$291B
$3.25M 0.59%
27,683
+1,440
+5% +$167K
PFE icon
46
Pfizer
PFE
$145B
$3.1M 0.57%
97,360
+11,974
+14% +$378K
VCLT icon
47
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.88B
$2.95M 0.54%
31,640
-6,719
-18% -$617K
IVW icon
48
iShares S&P 500 Growth ETF
IVW
$77.5B
$2.88M 0.53%
84,032
-2,000
-2% -$67.8K
JPM icon
49
JPMorgan Chase
JPM
$956B
$2.71M 0.5%
29,638
+2,808
+10% +$242K
CB icon
50
Chubb
CB
$134B
$2.57M 0.47%
17,704
+496
+3% +$69.8K

Similar funds

Thomasville National Bank's Q2 2017 Portfolio in Review

As of Q2 2017, Thomasville National Bank held 263 positions worth $547M, up 8.8% from $503M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Thomasville National Bank deployed $35.8M of net new capital in Q2 2017, opening 29 new positions and adding to 142 existing holdings. Its largest new stake was Celgene Corp: 37,525 shares worth $4.87M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.9M trimmed.

  • Thomasville National Bank's largest Q2 2017 buy was Celgene Corp: 37,525 shares worth $4.87M.
  • Thomasville National Bank added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $10.1M increase.
  • Thomasville National Bank's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $3.9M.
  • Thomasville National Bank fully exited Novo Nordisk in Q2 2017, selling an estimated $2.63M.
  • Thomasville National Bank's ten largest holdings make up 28% of its $547M portfolio in Q2 2017.
  • Thomasville National Bank opened 29 new positions and closed 13 in Q2 2017.
  • Thomasville National Bank's portfolio value rose 8.8% quarter-over-quarter to $547M.

Based on Thomasville National Bank's 13F filing for Q2 2017, filed 17 Jul 2017.